相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Reevaluating Rifampicin Breakpoint Concentrations for Mycobacterium tuberculosis Isolates with Disputed rpoB Mutations and Discordant Susceptibility Phenotypes
Wei Wang et al.
Microbiology Spectrum (2022)
Low-Level Rifampin Resistance and rpoB Mutations in Mycobacterium tuberculosis: an Analysis of Whole-Genome Sequencing and Drug Susceptibility Test Data in New York
Joseph Shea et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2021)
On the Consequences of Poorly Defined Breakpoints for Rifampin Susceptibility Testing of Mycobacterium tuberculosis Complex
Claudio U. Koser et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2021)
Mycobacterium tuberculosis borderline rpoB mutations: emerging from the unknown
Armand Van Deun et al.
EUROPEAN RESPIRATORY JOURNAL (2021)
rpoB Mutations and Effects on Rifampin Resistance in Mycobacterium tuberculosis
Ma-chao Li et al.
INFECTION AND DRUG RESISTANCE (2021)
rpoB Mutations Causing Discordant Rifampicin Susceptibility in Mycobacterium tuberculosis: Retrospective Analysis of Prevalence, Phenotypic, Genotypic, and Treatment Outcomes
Nomonde R. Mvelase et al.
OPEN FORUM INFECTIOUS DISEASES (2019)
Regimens to treat multidrug-resistant tuberculosis: past, present and future perspectives
Emanuele Pontali et al.
EUROPEAN RESPIRATORY REVIEW (2019)
Variable ability of rapid tests to detect Mycobacterium tuberculosis rpoB mutations conferring phenotypically occult rifampicin resistance
Gabriela Torrea et al.
SCIENTIFIC REPORTS (2019)
Advantages of the AdvanSure MDR-TB GenoBlot assay containing disputed rpoB mutation-specific probes in a routine clinical laboratory setting
In Young Yoo et al.
RESPIRATORY MEDICINE (2019)
Absence of hybridization with the wild-type and mutant rpoB probes in the Genotype MTBDRplus assay detects 'disputed' rifampicin mutations
N. N. Abanda et al.
CLINICAL MICROBIOLOGY AND INFECTION (2018)
Multi and extensively drug-resistant pulmonary tuberculosis: advances in diagnosis and management
Emanuele Pontali et al.
CURRENT OPINION IN PULMONARY MEDICINE (2018)
Role of Disputed Mutations in the rpoB Gene in Interpretation of Automated Liquid MGIT Culture Results for Rifampin Susceptibility Testing of Mycobacterium tuberculosis
Paolo Miotto et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2018)
What Is Resistance? Impact of Phenotypic versus Molecular Drug Resistance Testing on Therapy for Multi-and Extensively Drug-Resistant Tuberculosis
Jan Heyckendorf et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Frequency and Type of Disputed rpoB Mutations in Mycobacterium tuberculosis Isolates from South Korea
Kyung-Wook Jo et al.
TUBERCULOSIS AND RESPIRATORY DISEASES (2017)
Rifabutin and rifampin resistance levels and associated rpoB mutations in clinical isolates of Mycobacterium tuberculosis complex
Zenda L. Berrada et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2016)
Profiling of rpoB Mutations and MICs for Rifampin and Rifabutin in Mycobacterium tuberculosis
F. B. Jamieson et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2014)
Rifampin Drug Resistance Tests for Tuberculosis: Challenging the Gold Standard
Armand Van Deun et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2013)
The Rationale for Using Rifabutin in the Treatment of MDR and XDR Tuberculosis Outbreaks
Frederick A. Sirgel et al.
PLOS ONE (2013)
Molecular characterization of drug-resistant and -susceptible Mycobacterium tuberculosis isolated from patients with tuberculosis in Korea
Jee-Hyun Yoon et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2012)
Rapid Diagnosis of Tuberculosis and Multidrug Resistance Using a MGIT 960 System
Won-Jung Koh et al.
ANNALS OF LABORATORY MEDICINE (2012)